DOCSLIB.ORG

Index Medicus for the Eastern Mediterranean Region (IMEMR) Monazamet El Seha El Alamia Street Extension of Abdel Razak El Sanhouri Street P.O

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Index Medicus for the Eastern Mediterranean Region (IMEMR) Monazamet El Seha El Alamia Street Extension of Abdel Razak El Sanhouri Street P.O ISSN: 2071-2510 Vol. 11 No.2 For further information contact: World Health Organization Regional Office for the Eastern Mediterranean Knowledge Sharing and Production (KSP) Index Medicus for the Eastern Mediterranean Region (IMEMR) Monazamet El Seha El Alamia Street Extension of Abdel Razak El Sanhouri Street P.O. Box 7608, Nasr City Cairo 11371, Egypt Tel: +20 2 22765047 IMEMR Current Contents Fax: +20 2 22765424 December 2017 e-mail: [email protected] Vol. 16 No. 4 Providing Access to Health Knowledge to Build a Healthy Future http://www.emro.who.int/information-resources/imemr/imemr.html Index Medicus for the WHO Eastern Mediterranean Region with Abstracts IMEMR Current Contents December 2017 Vol. 16 No. 4 © World Health Organization 2017 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate borderlines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Publications of the World Health Organization can be obtained from Health Publications, Production and Dissemination, World Health Organization, Regional Office for the Eastern Mediterranean, P.O. Box 7608, Nasr City, Cairo 11371, Egypt (tel: + 202 2276 043, fax: +202 22765 424; email: [email protected]). Requests for permission to reproduce, in part or in whole, or to translate publications of WHO Regional Office for the Eastern Mediterranean – whether for sale or for noncommercial distribution – should be addressed to Regional Adviser, Global Arabic Programme, WHO Regional Office for the Eastern Mediterranean, at the following address: email: [email protected]. Design, layout and printing by WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt ISSN: 2071-2510 Table of Contents IMEMR Current Contents ................................................................................................................ v Subject Index ................................................................................................................................ vii Abdominal Injuries ....................................................................................................................................... 1 Acne Vulgaris ............................................................................................................................................... 1 Aconitum ..................................................................................................................................................... 2 Agriculture ................................................................................................................................................... 2 Aloe .............................................................................................................................................................. 2 Ampulla of Vater .......................................................................................................................................... 3 Anastomosis, Surgical .................................................................................................................................. 3 Annona......................................................................................................................................................... 3 Anticonvulsants............................................................................................................................................ 4 Antitubercular Agents .................................................................................................................................. 4 Anus, Imperforate ........................................................................................................................................ 5 Artemisia absinthium ................................................................................................................................... 6 Arterial Occlusive Diseases .......................................................................................................................... 6 Arthrocentesis .............................................................................................................................................. 7 Bees ............................................................................................................................................................. 7 beta-Thalassemia ......................................................................................................................................... 7 Biliary Tract Diseases ................................................................................................................................... 8 Bioethics ...................................................................................................................................................... 8 Brassica ........................................................................................................................................................ 8 Breast Neoplasms ........................................................................................................................................ 9 Burns .......................................................................................................................................................... 10 C-Reactive Protein...................................................................................................................................... 10 Candidiasis, Vulvovaginal ........................................................................................................................... 11 Captopril .................................................................................................................................................... 11 Carcinoma, Hepatocellular ......................................................................................................................... 11 Carotid Artery Diseases .............................................................................................................................. 12 Catheterization, Peripheral ........................................................................................................................ 12 Cerebral Hemorrhage ................................................................................................................................ 13 Cesarean Section, Repeat .......................................................................................................................... 13 Cholecystectomy ........................................................................................................................................ 14 Chromones ................................................................................................................................................. 15 Cisplatin ..................................................................................................................................................... 15 Clobetasol .................................................................................................................................................. 15 Clonidine .................................................................................................................................................... 16 Colorectal Neoplasms ................................................................................................................................ 16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities ........................................................... 17 Coronary Artery Disease ............................................................................................................................ 17 Coronavirus Infections ............................................................................................................................... 18 Craniocerebral Trauma .............................................................................................................................. 18 Crocus ........................................................................................................................................................ 18 Cross Infection ........................................................................................................................................... 19 Curcumin ...................................................................................................................................................
Load more

Recommended publications
  • Afghanistan and the Central Asian Question
    i Digitized by tine Internet Arciiive in 2008 with funding from IVIicrosoft Corporation http://www.archive.org/details/afghanistancentrOOfishrich AFGHANISTAN AND THE CENTRAL ASIAN QUESTION. : AFGHANISTAN AND THE CENTRAL ASIAN QUESTION BY I FRED. H. FISHER, A. LOND., OK THP: MIDDLE TEMPLE, AND H.M. BENGAL CIVIL SERVICE: Aict/ioi- of ^' Cy/>>iis, our Nciv Colony, ajid what we know about it." WITH MAP. lLontion JAMES CLARKE & CO., 13 & 14, FLEET STREET, E.C. 1878. D52>5 T5 '^ For my own part, I will only say that though I sliould have preferred, in the interest of peace, that Russia had not entered on a career of conquest along the Jaxartes and the Oxus, yet I see no reason at present to feel any anxiety about the advance towards India, Asia is large enough for both of us, and we may well pursue our respective paths, ajid fulfil our respective missions, without jostling or jealousy. Our positio7i in Asia is quiescent, while hers is progressive. We can, therefore^ well affoi'd to wait, forbearing, but vigilant, and conscious that if real danger approaches at any time, we are strong enoiigh to arrest and crush it."—SiR Henky Rawlinson's "Notes on Khiva," March, iSyj. HENRY MORSE STEPHENS PREFACE. The author's best apology for the present book must be the absence of any single English work, so far, at least, as he knows, which professes to give a comprehensive account of the land of the Afghans, the people, and their history, including all that is most important in the past, as well as the more immediately interesting subject of the present, re- lations of Afghanistan with Great Britain.
    [Show full text]
  • Schedule Book
    Monday Morning, April 26, 2021 Live Session Room Live - Session LI-MoM1 Coatings for Flexible Electronics and Bio Applications Live Session Moderators: Dr. Jean Geringer, Ecole Nationale Superieure des Mines, France, Dr. Grzegorz (Greg) Greczynski, Linköping University, Sweden, Dr. Christopher Muratore, University of Dayton, USA, Dr. Barbara Putz, Empa, Switzerland 10:00am LI-MoM1-1 ICMCTF Chairs' Welcome Address, G. Greczynski, Linköping University, Sweden; C. Muratore, University of Dayton, USA 10:15am INVITED: LI-MoM1-2 Plenary Lecture: Organic Bioelectronics – Nature Connected, M. Berggren, Linköping University, Norrköping, Sweden 10:30am 10:45am 11:00am BREAK 11:15am INVITED: LI-MoM1-6 Flexible Printed Sensors for Biomechanical Measurements, T. Ng, University of California San Diego, USA 11:30am 11:45am INVITED: LI-MoM1-8 Flexible Electronics: From Interactive Smart Skins to In vivo Applications, D. Makarov, Helmholtz-Zentrum Dresden-Rossendorf e. V. (HZDR), Institute of Ion Beam Physics and Materials Research, Germany 12:00pm 12:15pm INVITED: LI-MoM1-10 Biomimetic Extracellular Matrix Coating for Titanium Implant Surfaces to Improve Osteointegration, S. Ravindran, P. Gajendrareddy, J. Hassan, C. Huang, University of Illinois at Chicago, USA 12:30pm 12:45pm LI-MoM1-12 Closing Remarks & Thank You!, C. Muratore, University of Dayton, USA; G. Greczynski, Linköping University, Sweden, USA Monday Morning, April 26, 2021 1 10:00 AM Monday Morning, April 26, 2021 Live Session Room Live - Session LI-MoM2 New Horizons in Boron-Containing Coatings Live Session Moderators: Mr. Marcus Hans, RWTH Aachen University, Germany, Dr. Helmut Riedl, TU Wien, Institute of Materials Science and Technology, Austria 11:00am LI-MoM2-1 Welcome & Thank You to Sponsors, M.
    [Show full text]
  • Protectores De La Cultura Y La Biodiversidad
    Protectores de la cultura y la biodiversidad Los Pueblos Indígenas se hacen cargo de sus desafíos y oportunidades Anita Kelles-Viitanen para el Fondo Internacional de Desarrollo Agrícola (FIDA) Financiado por Iniciativa del FIDA para la Integración de Innovaciones de FIDA y el Gobierno de Finlandia Contenido Resumen Ejecutivo 3 I. Objetivo del Estudio II. Resultados y Recomendaciones 4 1. Introducción 4 2. Pobreza 5 3. Medios de subsistencia 5 4. Calentamiento global 6 5. Territorios 5 6. Biodiversidad y administración de los recursos naturales 8 7. Culturas Indigenas 9 8. Género 10 9. Construcción de Organizaciones y participación 10 10. ¿Un nuevo modelo de desarrollo? 11 11. Algunas observaciones para el futuro del Fondo de Apoyo para los Pueblos Indígenas 9 Análisis Regionales III. Región de Asia y el Pacífico 1. Asia del Sur 15 2. Sudeste Asiático 23 3. El Pacifico 29 4. Países Asiáticos en transición 24 IV. Cercano Oriente y Norte de África 25 V. Este y Sur de África 1. Países Islas 26 2. Región del Sur de África 26 3. Región del Este de África 27 4. Región de África Central 29 5. Región del África Occidental 30 VI. América Latina 1. Centroamérica 40 2. Sudamérica 48 3. Norteamérica 62 VII. Región del Caribe 52 Bibliografía 52 2 “Los Pueblos Indígenas son el rostro humano del calentamiento global.” Victoria Tauli-Corpuz Resumen Ejecutivo El presente estudio fue realizado en base a la revisión de 1095 proyectos que proponen soluciones a la pobreza rural presentados por los Pueblos Indígenas y sus organizaciones. La información contenida en estas propuestas posee limitaciones intrínsecas.
    [Show full text]
  • 28 Practical Dermatology March 2008
    he influence of “the literature” on daily medical ings from a Merck-sponsored study of rofecoxib, alleging that practice is incalculable. Through it, researchers manuscript authors suppressed evidence of cardiac effects caused share and pursue additional avenues of discovery, by the medication. Certainly peer reviewers can assess the infor- while clinicians uncover the latest information mation presented in a publication, but they cannot know what about new patient care strategies. Without pub- relevant information is not presented. Tlished studies documenting the efficacy of new drugs, physicians According to the International Committee of Medical would be hard-pressed to adopt them into practice. Every clini- Journal Editors (ICMJE), a peer-reviewed journal is “one that cian has at some point mined the literature for clues to the diag- submits most of its published research articles for outside nosis or management of a challenging case. The literature can review.” The group of general medical journal editors whose par- even influence insurance coverage decisions, as companies deter- ticipants meet annually and produce the Uniform Requirements mine broad policies and decide case-by-case coverage based on for Manuscripts (URM), acknowledges that, “The number and available published evidence. kind of manuscripts sent for review, the number of reviewers, the It is incumbent upon physicians to keep abreast of the litera- reviewing procedures, and the use made of the reviewers’ opin- ture relevant to their field of practice. Yet familiarity with med- ions may vary. In the interests of transparency, each journal ical journals may breed complacency; those who depend on should publicly disclose its policies in its instructions to these publications may take for granted the quality of informa- authors.” Among US journals, both the Journal of the American tion presented in the canon of the literature while unduly dis- Academy of Dermatology and Archives of Dermatology follow the missing other worthy sources of pertinent, quality information.
    [Show full text]
  • A Study of Incidence of Congenital Cardiac Anomalies in the New- Borns with Ano-Rectal Malformation: Our Hospital Experience
    Original Research Article Indian Journal of Anesthesia and Analgesia1973 2018; 5(12): 1973­76 DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.51218.1 A Study of Incidence of Congenital Cardiac Anomalies in the New- Borns with Ano-Rectal Malformation: Our Hospital Experience Y.V.S. Ravi Nagaprasad1, Aavula Muralidhar2 1,2Associate Professor, Department of Anesthesiology, Niloufer Hospital for Women and Child, Osmania Medical Collage, Hyderabad, Telangana 500095, India. Abstract Background: Ano­rectal malformation is a common anomaly seen in newborns and is associated with multiple anomalies like renal, vertebral, muscular and cardiac. Associated cardiac anomalies determine the morbidity and mortality of newborn. It is mandatory to properly evaluate the child for cardiac anomalies in children with ARM. Objective: The aim of the study is to evaluate the incidence of associated cardiac anomalies in thenew­borns with Ano­rectal malformation admitted ina tertiary care centre. Method: Total number of Ano­rectal Malformation admitted from June 2017 to May 2018 in our hospital was recorded. All cases after examination and evaluation were classified into Low ARM and High ARM. All cases after preoperative evaluations and basic haematological tests were taken for emergency colostomy or cut back anoplasty. Patients during postoperative period were performed echocardiogram for cardiac evaluation. Total number newborns with ARM having associated cardiac anomalies were determined. The incidence of cardiac anomalies in two types of ARM was determined. Results: Total number of newborns with ARM admitted for sugery in the period of June 2017 to May 2018 were 182. Out of which 21 cases were having congenital cardiac anomalies (11.53%).
    [Show full text]
  • PATHOLOGY, Faculty of Medicine, Institute of Medical Sciences A
    FORMAT FOR SUBJECTWISE IDENTIFYING JOURNALS BY THE UNIVERSITIES AND APPROVAL OF THE UGC {Under Clause 6.05 (1) of the University Grants Commission (Minimum Qualifications for appointment of Teacher and Other Academic Staff in Universities and Colleges and Measures for the Maintenance of Standards in Higher Education (4th Amendment), Regulations, 2016} Subject: PATHOLOGY, Faculty of Medicine, Institute of Medical Sciences A. Refereed Journals Sl. Name of the Journal Publisher and Year of Hard e-publication ISSN Number Peer / Indexing status. Impact Do you use Any other No. place of Start copies (Yes/No) Refree If indexed, Factor/Rating. any Information publication published Reviewed Name of the Name of the IF exclusion (Yes/No) (Yes/No) indexing data assigning agency. criteria for base Whether covered Research by Thompson & Journals Reuter (Yes/No) 1 2 3 4 5 6 7 8 9 10 11 1 Acta cytologica Karger, Basel 1957 Yes Yes 0001-5547(Print); Yes Indexed (Index 1.562 (Impact (Switzerland) 1938- medicus, Medline, Factor by Thomson 2650(Electronic); Pubmed) Reuters) 0001-5547(Linking) 2 Acta oncologica Informa Healthcare, 1987 No Yes 0284-186X(Print); Yes Indexed (Index 3.730 (Impact London (England) 1651- medicus, Medline, Factor by Thomson 226X(Electronic); Pubmed) Reuters) 0284-186X(Linking) 3 Advances in anatomic pathology Lippincott Williams 1994 Yes Yes 1072-4109(Print); Yes Indexed (Index 2.919 (Impact & Wilkins, 1533- medicus, Medline, Factor by Thomson Hagerstown, MD 4031(Electronic); Pubmed) Reuters) 1072-4109(Linking) 4 American journal of clinical oncology Lippincott Williams 1982 Yes Yes 0277-3732(Print); Yes Indexed (Index 2.977 (Impact & Wilkins, 1537- medicus, Medline, Factor by Thomson Hagerstown, MD 453X(Electronic); Pubmed) Reuters) 0277-3732(Linking) Sl.
    [Show full text]
  • 付表 ⅠA 指定を受けた医薬の有効成分 Annex ⅠA Designated
    付表ⅠA 指定を受けた医薬の有効成分 Annex ⅠA Designated Pharmaceutical Active Ingredients 号(Sub-heading) 品名 Description 2818.30 アルゲルドラート algeldrate 2833.22 アルスルフ alusulf 2842.10 アルマシラート almasilate 2842.10 シマルドラート simaldrate 2842.90 硫酸アルマドラ ート almadrate sulfate 2842.90 アルマガート almagate 2842.90 カルバルドラード carbaldrate 2842.90 ヒドロタルシト hydrotalcite 2842.90 マガルドラート magaldrate 2843.30 オーラノフィン auranofin 2843.30 金チオグリカニド aurothioglycanide 2843.30 金チオりんご酸ナトリウム sodium aurothiomalate 2843.30 金チオ硫酸ナトリウム sodium aurotiosulfate 2843.90 カルボプラチン carboplatin 2843.90 シスプラチン cisplatin 2843.90 デキソルマプラチン dexormaplatin 2843.90 エンロプラチン enloplatin 2843.90 イプロプラチン iproplatin 2843.90 ロバプラチン lobaplatin 2843.90 ミボプラチン miboplatin 2843.90 ネダプラチン nedaplatin 2843.90 オルマプラチン ormaplatin 2843.90 オキサリプラチン oxaliplatin 2843.90 セブリプラチン sebriplatin 2843.90 スピロプラチン spiroplatin 2843.90 ゼニプラチン zeniplatin 2844.40 アルツモマブ altumomab 2844.40 塩化セシウム(131Cs) cesium (131 Cs) chloride 2844.40 クロルメロドリン(197Hg) chlormerodrin (197 Hg) 2844.40 シアノコバラミン(57Co) cyanocobalamin (57 Co) 2844.40 シアノコバラミン(58Co) cyanocobalamin (58 Co) 2844.40 シアノコバラミン(60Co) cyanocobalamin (60 Co) 2844.40 エチオダイズド油(131I) ethiodized oil (131 I) 2844.40 くえん酸第二鉄(59Fe)注射液 ferric (59 Fe) citrate in 2844.40 フィブリノゲン(125I) fibrinogen (125 I) 2844.40 フルデオキシグルコー ス(18F) fludeoxyglucose ( 18 F) 2844.40 フルオロドパ(18F) fluorodopa (18 F) 2844.40 くえん酸ガリウム(67Ga) gallium (67 Ga) citrate 2844.40 金コロイド(198Au) gold (198 Au), colloidal 2844.40 イオベングアン(131I) iobenguane (131 I) 2844.40 よう化人血清アルブミン(125I) iodinated (125 I) human serum albumin 2844.40 よう化人血清アルブミン(131I) iodinated
    [Show full text]
  • Using Pubmed …For Searching the MEDLINE Database
    UUssiinngg PPuubbMMeedd …for searching the MEDLINE database Available online at http://pubmed.gov A condensed version of the National Training Center and Clearinghouse’s NLM Training: PubMed Compiled by New England Region of the National Network of Libraries of Medicine University of Massachusetts Medical School Worcester, MA Reprints: Phone 800-338-7657 July 2004 Searching MEDLINE PubMed Pubmed.gov 1 Searching MEDLINE PubMed TABLE OF CONTENTS PUBLISHER SUPPLIED CITATIONS ....................................................................................................................4 IN PROCESS CITATIONS........................................................................................................................................5 OTHER PUBLISHER SUPPLIED CITATIONS.....................................................................................................5 MEDLINE & MEDLINE CITATIONS ....................................................................................................................5 OLDMEDLINE CITATIONS ....................................................................................................................................6 PUBMED SIDEBAR ...................................................................................................................................................7 SEARCHING WITH PUBMED ................................................................................................................................8 WHAT IS SEARCHED?.............................................................................................................................................8
    [Show full text]
  • Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress—Related Neurodegeneration
    International Journal of Molecular Sciences Review Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress—Related Neurodegeneration Cristina Angeloni 1 , Martina Gatti 2, Cecilia Prata 3,* , Silvana Hrelia 4 and Tullia Maraldi 2 1 School of Pharmacy, University of Camerino, Via Gentile III da Varano, 62032 Camerino, Italy; [email protected] 2 Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, Via del Pozzo 71, 41124 Modena, Italy; [email protected] (M.G.); [email protected] (T.M.) 3 Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Irnerio 48, 40126 Bologna, Italy 4 Department for Life Quality Studies, Alma Mater Studiorum—University of Bologna, Corso d’Augusto 237, 47921 Rimini, Italy; [email protected] * Correspondence: [email protected] Received: 7 April 2020; Accepted: 4 May 2020; Published: 7 May 2020 Abstract: Neurodegenerative diseases include a variety of pathologies such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and so forth, which share many common characteristics such as oxidative stress, glycation, abnormal protein deposition, inflammation, and progressive neuronal loss. The last century has witnessed significant research to identify mechanisms and risk factors contributing to the complex etiopathogenesis of neurodegenerative diseases, such as genetic, vascular/metabolic, and lifestyle-related factors, which often co-occur and interact with each other. Apart from several environmental or genetic factors, in recent years, much evidence hints that impairment in redox homeostasis is a common mechanism in different neurological diseases. However, from a pharmacological perspective, oxidative stress is a difficult target, and antioxidants, the only strategy used so far, have been ineffective or even provoked side effects.
    [Show full text]
  • Developing a Chaotic Pattern of Dynamic Hazmat Routing Problem☆
    IATSSR-00059; No of Pages 9 IATSS Research xxx (2013) xxx–xxx Contents lists available at SciVerse ScienceDirect IATSS Research Developing a chaotic pattern of dynamic Hazmat routing problem☆ Abbas Mahmoudabadi a,⁎, Seyed Mohammad Seyedhosseini b a Department of Industrial Engineering, Payam-e-Noor University, Tehran, Iran b Department of Industrial Engineering, Iran University of Science & Technology, Tehran, Iran article info abstract Article history: The present paper proposes an iterative procedure based on chaos theory on dynamic risk definition to Received 25 September 2012 determine the best route for transporting hazardous materials (Hazmat). In the case of possible natural disas- Received in revised form 15 June 2013 ters, the safety of roads may be seriously affected. So the main objective of this paper is to simultaneously Accepted 27 June 2013 improve the travel time and risk to satisfy the local and national authorities in the transportation network. Available online xxxx Based on the proposed procedure, four important risk components including accident information, popula- tion, environment, and infrastructure aspects have been presented under linguistic variables. Furthermore, the Keywords: Hazmat routing problem extent analysis method was utilized to convert them to crisp values. To apply the proposed procedure, a road net- Chaos theory work that consists of fifty nine nodes and eighty two-way edges with a pre-specified affected area has been con- Emergency situations sidered. The results indicate that applying the dynamic risk is more appropriate than having a constant risk. The Dynamic risk analysis application of the proposed model indicates that, while chaotic variables depend on the initial conditions, the Linguistic variables most frequent path will remain independent.
    [Show full text]
  • A Study on Etiology and Incidence of Formation of Types of Anorectal Malformation
    International Journal of Surgery Science 2019; 3(4): 100-103 E-ISSN: 2616-3470 P-ISSN: 2616-3462 © Surgery Science A study on Etiology and incidence of formation of types www.surgeryscience.com 2019; 3(4): 100-103 of Anorectal malformation: A prospective study Received: 18-08-2019 Accepted: 22-09-2019 Dr. Mohd Zakir Mohiuddin Owais, Dr. T Vinodh Kumar, Dr. Hasanthi, Dr. Mohd Zakir Mohiuddin Owais Assistant Professor, Department of R Suman and A Madhu Paediatric Surgery, Niloufer Hospital, Hyderabad, Telangana, DOI: https://doi.org/10.33545/surgery.2019.v3.i4b.225 India Abstract Dr. T Vinodh Kumar Background: Anorectal malformations are one of the most common congenital defects. This study was Assistant Professor, Department of undertaken to study the hospital incidence of anorectal malformations (ARM), frequency of various types Paediatric Surgery, Sri Venkateswara Medical College, of defects, their sex distribution and the spectrum of anomalies associated with ARM. Tirupati, Andhra Pradesh, India Materials and Methods: Ninety consecutive children attending the paediatric surgery department were included in this study. A detailed history was taken, and examination was performed for the primary as Dr. Hasanthi well as the associated defects. Appropriate investigations like invertogram, cologram were done wherever Assistant Professor, Department of indicated. Management was as per the standard protocol. The data was recorded and analyzed. Paediatric Surgery, Guntur Results: Out of the 90 patients, 52(57.77%) male patients and 38(42.22%) female patients. Most of our Medical College & Govt General patients presented within first 24 hours of life. Patients who presented after 72 hours were either female Hospital, Guntur, Andhra Pradesh, patients with anovestibular malformation or male patients with anocutaneous fistula.
    [Show full text]
  • Life Science Journal 2013;10(9S) Http
    Life Science Journal 2013;10(9s) http://www.lifesciencesite.com Studying Mistaken Theory of Calendar Function of Iran’s Cross-Vaults Ali Salehipour Department of Architecture, Heris Branch, Islamic Azad University, Heris, Iran [email protected] Abstract: After presenting the theory of calendar function of Iran’s cross-vaults especially “Niasar” cross-vault in recent years, there has been lots of doubts and uncertainty about this theory by astrologists and archaeologists. According to this theory “Niasar cross-vault and other cross-vaults of Iran has calendar function and are constructed in a way that sunrise and sunset can be seen from one of its openings in the beginning and middle of each season of year”. But, mentioning historical documentaries we conclude here that the theory of calendar function of Iran’s cross-vaults does not have any strong basis and individual cross-vaults had only religious function in Iran. [Ali Salehipour. Studying Mistaken Theory of Calendar Function of Iran’s Cross-Vaults. Life Sci J 2013;10(9s):17-29] (ISSN:1097-8135). http://www.lifesciencesite.com. 3 Keywords: cross-vault; fire temple; Calendar function; Sassanid period 1. Introduction 2.3 Conformity Of Cross-Vaults’ Proportions With The theory of “calendar function of Iran’s Inclined Angle Of Sun cross-vaults” is a wrong theory introduced by some The proportion of “base width” to “length of interested in astronomy in recent years and this has each side” of cross-vault, which is a fixed proportion caused some doubts and uncertainties among of 1 to 2.3 to 3.9 makes 23.5 degree arch between researchers of astronomy and archaeologists but the edges of bases and the visual line created of it except some distracted ideas, there has not been any which is equal to inclining edge of sun.
    [Show full text]